The Woburn, Mass.-based polymer gel developer wins 510(k) approval from the FDA for its Backstop gel plug.
Pluromed Inc. won 510(k) approval from the Food & Drug Administration for its Backstop polymer gel plug.
The Woburn, Mass.-based firm's product is used during lithotripsy kidney stone treatments that use laser or other energy sources to break up the stones. Backstop uses Pluromed's Rapid Transition Polymers, which are liquid at low temperatures but gel at 98.6 degrees Fahrenheit.
During the lithotripsy, the gel forms a plug above the stones, preventing them from moving during the procedure. Once they're broken up, saline is used to dissolve the plug.
Hologic wins FDA approval for its new C-View 2D imaging software for use with its 3D breast...
The hallowed emerging markets in Brazil, Russia, India and China aren't generating the kind of growth...
Medical device company Bausch + Lomb won FDA approval for its Trulign Toric intraocular lens, the 1st...
California medical device maker Claret Medical's embolic protection technology captures debris...
Texas-based Galt Medical Corp. is reportedly laying off 139 workers as it shutters its hometown plant...